Protocol for assessing T cell receptor-mediated human T cell cytotoxicity

被引:0
|
作者
Marks, Kathryne E. [1 ,2 ]
Adejoorin, Ifeoluwakiisi [1 ]
Sowerby, John [1 ,2 ]
Rao, Deepak A. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源
STAR PROTOCOLS | 2025年 / 6卷 / 01期
关键词
FAS;
D O I
10.1016/j.xpro.2024.103541
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Measuring the cytotoxicity of human T cells is a valuable but challenging task. We present a protocol for assessing the ability of polyclonal human T cells to kill target cells upon T cell receptor (TCR) triggering. We describe steps for preparing Land T cells for the assay and incubation of target cells with effector cells. We detail procedures for assessing cell death by flow cytometry. This protocol can be applied to small numbers of effector cells isolated from patient samples. For complete details on the use and execution of this protocol, please refer to Wang et al.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Efficient T cell receptor-mediated apoptosis in nonobese diabetic mouse thymocytes
    Villunger, A
    Marsden, VS
    Strasser, A
    NATURE IMMUNOLOGY, 2003, 4 (08) : 717 - 717
  • [42] RESISTANCE TO T-CELL RECEPTOR-MEDIATED APOPTOSIS BY AUTOIMMUNE LPR THYMOCYTES
    CASTRO, I
    WANG, Y
    LISTMAN, J
    FINN, PW
    PERKINS, DL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 824 - 824
  • [43] ACCESSORY CELL REQUIREMENTS FOR RECEPTOR-MEDIATED ACTIVATION OF RESTING T-CELLS
    HATHCOCK, KS
    SEGAL, DM
    HODES, RJ
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 457 - 457
  • [44] Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner
    Seggewiss, R
    Loré, K
    Greiner, E
    Magnusson, MK
    Price, DA
    Douek, DC
    Dunbar, CE
    Wiestner, A
    BLOOD, 2005, 105 (06) : 2473 - 2479
  • [45] Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis
    Masami Fujii
    Keitaro Hayashi
    Masaru Niki
    Natsuko Chiba
    Kuniaki Meguro
    Kazuyasu Endo
    Junichi Kameoka
    Sadayoshi Ito
    Keishi Abe
    Toshio Watanabe
    Masanobu Satake
    Oncogene, 1998, 17 : 1813 - 1820
  • [46] The Characteristic T-Cell Receptor-Mediated Signaling of Peripheral Blood T Cells in Dermatomyositis and Polymyositis
    Shimojima, Yasuhiro
    Kishida, Dai
    Sekijima, Yoshiki
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis
    Fujii, M
    Hayashi, K
    Niki, M
    Chiba, N
    Meguro, K
    Endo, K
    Kameoka, J
    Ito, S
    Abe, K
    Watanabe, T
    Satake, M
    ONCOGENE, 1998, 17 (14) : 1813 - 1820
  • [48] A DEFECT IN THE EARLY PHASE OF T-CELL RECEPTOR-MEDIATED T-CELL ACTIVATION IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY
    FISCHER, MB
    HAUBER, I
    EGGENBAUER, H
    THON, V
    VOGEL, E
    SCHAFFER, E
    LOKAJ, J
    LITZMAN, J
    WOLF, HM
    MANNHALTER, JW
    EIBL, MM
    BLOOD, 1994, 84 (12) : 4234 - 4241
  • [49] Differential T cell receptor-mediated signaling in naive and memory CD4 T cells
    Farber, DL
    Acuto, O
    Bottomly, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) : 2094 - 2101
  • [50] The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses
    Freywald, A
    Sharfe, N
    Rashotte, C
    Grunberger, T
    Roifman, CM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) : 10150 - 10156